Evidence map›Paper›PMID 30915370›Full record

ArticleJournal of immunology research2019

Increased TLR4 Expression Aggravates Sepsis by Promoting IFN-

Qi Li, Chenyi Wu, Zhenlong Liu, Huiqing Zhang, Yuna Du, Yuxiang Liu, Kuangyu Song, Qiaofa Shi, Rong Li

Open access · goldAbstract read
In one paragraph

Article in Journal of immunology research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. CD38 ligation in sepsis promotes nicotinamide phosphoribosyltransferase-mediated IL-6 production in kidney stromal cells.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2025
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Qi LiDepartment of Medical Microbiology & Immunology and Laboratory of Infection & Immunity, School of Basic Medical Sciences, Nanchang University, Nanchang 330006, China.ORCID 0000-0002-6016-9081
Chenyi WuDepartment of Medical Microbiology & Immunology and Laboratory of Infection & Immunity, School of Basic Medical Sciences, Nanchang University, Nanchang 330006, China.ORCID 0000-0001-5641-7217
Zhenlong LiuMcGill University, Division of Experimental Medicine, Department of Medicine, Montreal, Quebec, Canada.
Huiqing ZhangDepartment of Medical Microbiology & Immunology and Laboratory of Infection & Immunity, School of Basic Medical Sciences, Nanchang University, Nanchang 330006, China.ORCID 0000-0002-9283-1973
Yuna DuDepartment of Medical Microbiology & Immunology and Laboratory of Infection & Immunity, School of Basic Medical Sciences, Nanchang University, Nanchang 330006, China.
Yuxiang LiuDepartment of Medical Microbiology & Immunology and Laboratory of Infection & Immunity, School of Basic Medical Sciences, Nanchang University, Nanchang 330006, China.ORCID 0000-0001-5115-2563
Kuangyu SongDepartment of Medical Microbiology & Immunology and Laboratory of Infection & Immunity, School of Basic Medical Sciences, Nanchang University, Nanchang 330006, China.ORCID 0000-0002-8770-0012
Qiaofa ShiDepartment of Medical Microbiology & Immunology and Laboratory of Infection & Immunity, School of Basic Medical Sciences, Nanchang University, Nanchang 330006, China.ORCID 0000-0002-0399-2346
Rong LiDepartment of Medical Microbiology & Immunology and Laboratory of Infection & Immunity, School of Basic Medical Sciences, Nanchang University, Nanchang 330006, China.ORCID 0000-0001-8503-7977
Nanchang University · CNMcGill University · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Gram-negative bacterial sepsis accounts for up to 50% worldwide sepsis that causes hospital mortality. Acute kidney injury (AKI), a common complication of Gram-negative bacterial sepsis, is caused by Toll-like receptor 4 (TLR4) activation. Lipopolysaccharide (LPS) is an endotoxin in Gram-negative bacteria and is recognized specifically by TLR4, which initiates innate immune response. Also, TLR4 signaling pathway activation is essential in response to LPS infection. CD38 is one of the well-known regulators of innate immunity, whose dysregulation contributes to sepsis. Many studies have proven that an attenuated Gram-positive bacterium induces sepsis in a CD38-blocking model. However, the pathogenesis of Gram-negative bacteria-induced sepsis in a CD38

Indexed as

Acute Kidney InjuryADP-ribosyl Cyclase 1AnimalsCytokinesGene Expression RegulationGram-Negative BacteriaImmunity, InnateInflammation MediatorsInterferon-gammaLipopolysaccharidesMiceMice, Inbred C57BLMice, KnockoutSepsisToll-Like Receptor 4ADP-ribosyl Cyclase 1CytokinesInflammation MediatorsInterferon-gammaLipopolysaccharidesTlr4 protein, mouseToll-Like Receptor 4

Identifiers

PMID30915370
PMCPMC6399547
OpenAlexW2916786655

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.